Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)

BVMF:PNVL3 Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	60	43.75	80	27.95	25.72	54.44
Trading Asset Securities	235.2	386.75	133.41	217.44	131.64	155.22
Cash & Short-Term Investments	295.2	430.5	213.41	245.39	157.36	209.65
Cash Growth	52.12%	101.72%	-13.03%	55.95%	-24.94%	-51.89%
Accounts Receivable	555.94	574.18	444.7	452.01	399.17	324.62
Other Receivables	123.77	125.94	182.88	142.13	105.48	121.78
Receivables	679.71	700.12	627.58	594.15	504.66	446.4
Inventory	1,204	1,167	1,152	999.41	896.54	739.04
Other Current Assets	5.89	0.41	20.08	1.12	-	-
Total Current Assets	2,185	2,298	2,013	1,840	1,559	1,395
Property, Plant & Equipment	1,334	1,335	1,174	1,081	1,034	874.11
Long-Term Investments	9.07	8.25	9.29	-	0	0.01
Goodwill	4.51	5.07	5.95	6.74	6.84	7.27
Other Intangible Assets	103.8	103.46	90.72	76.58	69.9	52.67
Long-Term Deferred Tax Assets	53.52	59.95	61.62	52.89	48.6	36.85
Other Long-Term Assets	20.22	20.83	23.23	19.08	13.27	12.05
Total Assets	3,710	3,831	3,377	3,077	2,733	2,381

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	644.29	725.31	630.82	679.76	555.45	464.71
Accrued Expenses	185.73	148.19	138.81	105.05	101.91	88.22
Current Portion of Long-Term Debt	146.28	191.82	162.93	102.54	118.4	54.53
Current Portion of Leases	139.91	136.89	129.8	164.36	152.09	134.61
Current Income Taxes Payable	1.48	6.89	5.76	2.15	1.76	0.67
Other Current Liabilities	132.19	111.59	116.54	80.55	78.62	72.24
Total Current Liabilities	1,250	1,321	1,185	1,134	1,008	814.97
Long-Term Debt	468.07	520.16	391.73	280	116.43	79.29
Long-Term Leases	649.49	657.4	551.35	475.79	484.62	422.5
Other Long-Term Liabilities	25.43	50.43	15	13.85	15.68	18.1
Total Liabilities	2,393	2,549	2,143	1,904	1,625	1,335

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,280	1,213	981.77	955.67	928.55	903.55
Retained Earnings	56.66	90.94	273.68	240.91	208.98	176.05
Treasury Stock	-10.29	-21.36	-23.99	-28.58	-35.14	-36.69
Comprehensive Income & Other	-8.93	-0.43	3.25	5.43	5.77	3.28
Shareholders' Equity	1,317	1,282	1,235	1,173	1,108	1,046
Total Liabilities & Equity	3,710	3,831	3,377	3,077	2,733	2,381

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,404	1,506	1,236	1,023	871.54	690.93
Net Cash (Debt)	-1,109	-1,076	-1,022	-777.3	-714.19	-481.28
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.35	-7.16	-6.80	-5.19	-4.79	-3.22
Filing Date Shares Outstanding	149.38	148.68	148.79	148.85	148.53	148.53
Total Common Shares Outstanding	149.38	148.68	148.79	148.85	148.53	148.53
Working Capital	935.4	976.92	827.92	705.65	550.31	580.11
Book Value Per Share	8.82	8.62	8.30	7.88	7.46	7.04
Tangible Book Value	1,209	1,173	1,138	1,090	1,031	986.25
Tangible Book Value Per Share	8.09	7.89	7.65	7.32	6.94	6.64
Machinery	423.49	409.49	365.11	252.64	218.56	180.18
Construction In Progress	37.11	22.78	14.36	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error